Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson’s disease-like pathology in neurons and glia
Martin T. Henrich, Fanni F. Geibl, Bolam Lee, et al.
Acta Neuropathologica Communications (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Locus coeruleus: a new look at the blue spot
Gina R. Poe, Stephen L. Foote, O Eschenko, et al.
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 644-659
Open Access | Times Cited: 523
The noradrenergic subtype of Parkinson disease: from animal models to clinical practice
К. Ray Chaudhuri, Valentina Leta, Kirsty Bannister, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 6, pp. 333-345
Closed Access | Times Cited: 42
Determinants of seeding and spreading of α-synuclein pathology in the brain
Martin T. Henrich, Fanni F. Geibl, Lakshminarasimhan Harini, et al.
Science Advances (2020) Vol. 6, Iss. 46
Open Access | Times Cited: 81
The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses
Asad Jan, Nádia Pereira Gonçalves, Christian B. Vægter, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8338-8338
Open Access | Times Cited: 77
Sleep and circadian rhythms in Parkinson’s disease and preclinical models
Jeremy Hunt, Elizabeth J. Coulson, Rajendram V. Rajnarayanan, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 63
α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson’s disease
Fanni F. Geibl, Martin T. Henrich, Zhong Xie, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys
Diana Alarcón-Arís, Rubén Pavia-Collado, Lluís Miquel-Rio, et al.
EBioMedicine (2020) Vol. 59, pp. 102944-102944
Open Access | Times Cited: 60
Animal models of brain-first and body-first Parkinson's disease
Nathalie Van Den Berge, Ayşe Ulusoy
Neurobiology of Disease (2021) Vol. 163, pp. 105599-105599
Open Access | Times Cited: 54
A Comprehensive Phenotype of Non-motor Impairments and Distribution of Alpha-Synuclein Deposition in Parkinsonism-Induced Mice by a Combination Injection of MPTP and Probenecid
Na‐Ra Han, Yu-Kang Kim, Sora Ahn, et al.
Frontiers in Aging Neuroscience (2021) Vol. 12
Open Access | Times Cited: 42
Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy
Lluís Miquel-Rio, Diana Alarcón-Arís, María Torres‐López, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Distinct Effects of Familial Parkinson’s Disease-Associated Mutations on α-Synuclein Phase Separation and Amyloid Aggregation
Bingkuan Xu, Fengshuo Fan, Yunpeng Liu, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 726-726
Open Access | Times Cited: 21
An experimental model of Braak’s pretangle proposal for the origin of Alzheimer’s disease: the role of locus coeruleus in early symptom development
Abhinaba Ghosh, Sarah E. Torraville, Bandhan Mukherjee, et al.
Alzheimer s Research & Therapy (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 53
Impaired Phasic Discharge of Locus Coeruleus Neurons Based on Persistent High Tonic Discharge—A New Hypothesis With Potential Implications for Neurodegenerative Diseases
Kathrin Janitzky
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 44
Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease
Laura M. Butkovich, Madelyn C. Houser, Termpanit Chalermpalanupap, et al.
Journal of Neuroscience (2020) Vol. 40, Iss. 39, pp. 7559-7576
Open Access | Times Cited: 41
Neuroprotection of Exendin-4 by Enhanced Autophagy in a Parkinsonian Rat Model of α-Synucleinopathy
Lu-Lu Bu, Yi-Qi Liu, Yan Shen, et al.
Neurotherapeutics (2021) Vol. 18, Iss. 2, pp. 962-978
Open Access | Times Cited: 33
Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson's disease
Analı́a Bortolozzi, Sharon Manashirov, Alon Chen, et al.
Pharmacology & Therapeutics (2021) Vol. 227, pp. 107873-107873
Open Access | Times Cited: 33
DRD1 signaling modulates TrkB turnover and BDNF sensitivity in direct pathway striatal medium spiny neurons
Thomas Andreska, Patrick Lüningschrör, Daniel H. Wolf, et al.
Cell Reports (2023) Vol. 42, Iss. 6, pp. 112575-112575
Open Access | Times Cited: 14
The locus coeruleus: Another vulnerability target in Parkinson's disease
Wolfgang H. Oertel, Martin T. Henrich, Annette Janzen, et al.
Movement Disorders (2019) Vol. 34, Iss. 10, pp. 1423-1429
Closed Access | Times Cited: 39
Post-Treatment with Erinacine A, a Derived Diterpenoid of H. erinaceus, Attenuates Neurotoxicity in MPTP Model of Parkinson’s Disease
Kam-Fai Lee, Shui‐Yi Tung, Chih‐Chuan Teng, et al.
Antioxidants (2020) Vol. 9, Iss. 2, pp. 137-137
Open Access | Times Cited: 33
Noradrenergic neuromodulation in ageing and disease
Friedrich Krohn, Elisa Lancini, Mareike Ludwig, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 152, pp. 105311-105311
Open Access | Times Cited: 12
Brain-to-gut trafficking of alpha-synuclein by CD11c+ cells in a mouse model of Parkinson’s disease
Rhonda L. McFleder, A. Makhotkina, Janos Groh, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Mood disturbances in Parkinson's disease: From prodromal origins to application of animal models
Shawn Hayley, F. Vahid-Ansari, Sun Hongyu, et al.
Neurobiology of Disease (2023) Vol. 181, pp. 106115-106115
Open Access | Times Cited: 11
Ion channel dysregulation and cellular adaptations to alpha-synuclein in stressful pacemakers of the parkinsonian brainstem
Wei‐Hua Chiu, Nadine Wattad, Joshua A. Goldberg
Pharmacology & Therapeutics (2024) Vol. 260, pp. 108683-108683
Closed Access | Times Cited: 4
Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, tau and alpha-synuclein
Jens Sobek, Junhao Li, Benjamin F. Combes, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 13, pp. 3960-3977
Open Access | Times Cited: 4
β-2 agonist and antagonist adrenoceptors induce neuroprotection in a progressive model of parkinsonism
Auderlan M. Gois, José M.M. Bispo, Edson R Santosa, et al.
Neuropharmacology (2025), pp. 110386-110386
Closed Access
Page 1 - Next Page

Scroll to top